Who
Paul Elliot Mann
Chairman and CEO
Company insider
Files Form 4 as: Chairman and CEO, ASP Isotopes; Director, Healthtech Solutions, Inc./UT; Director, Abeona Therapeutics; Chief Financial Officer, Polarityte.
In numbers
- Trades disclosed
- 74
- Buys
- 3
- Sells
- 26
- Bought
- $531K
- Sold
- $17.2M
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 18 Sep 2018
- Last trade
- 4 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Sep 2026filed 4 Sep 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $343K83,759 at $4.10 | filing |
| 4 Sep 2026filed 4 Sep 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $343K83,759 at $4.10 | filing |
| 3 Sep 2026filed 4 Sep 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $328K83,758 at $3.92 | filing |
| 3 Sep 2026filed 4 Sep 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $328K83,758 at $3.92 | filing |
| 2 Sep 2026filed 4 Sep 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $327K83,758 at $3.91 | filing |
| 2 Sep 2026filed 4 Sep 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $327K83,758 at $3.91 | filing |
| 3 Jun 2026filed 3 Jun 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $650K83,759 at $7.76 | filing |
| 3 Jun 2026filed 3 Jun 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $650K83,759 at $7.76 | filing |
| 2 Jun 2026filed 3 Jun 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $694K83,758 at $8.29 | filing |
| 2 Jun 2026filed 3 Jun 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $694K83,758 at $8.29 | filing |
| 1 Jun 2026filed 3 Jun 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $660K83,758 at $7.88 | filing |
| 1 Jun 2026filed 3 Jun 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $660K83,758 at $7.88 | filing |
| 28 May 2026filed 3 Jun 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Code A | —2,233,555 | filing |
| 28 May 2026filed 3 Jun 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Code A | —2,233,555 | filing |
| 2 Mar 2026filed 2 Mar 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $881K162,153 at $5.44 | filing |
| 2 Mar 2026filed 2 Mar 2026 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $882K162,153 at $5.44 | filing |
| 1 Dec 2025filed 3 Dec 2025 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $932K162,153 at $5.75 | filing |
| 25 Nov 2025filed 28 Nov 2025 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $289K50,000 at $5.77 | filing |
| 17 Nov 2025filed 28 Nov 2025 | ASPI ASP IsotopesChemicals | SEC FORM 4 Sold | $845K112,500 at $7.51 | filing |
| 9 Sep 2025filed 10 Sep 2025 | ASPI ASP Isotopesoption or derivative · Chemicals | SEC FORM 4 Code M | —216,000 at $0.00 | filing |
News
ASP Isotopes (NASDAQ:ASPI) CEO Paul Elliot Mann Sells 83,758 Sharestickerreport.com · 5 Sep 2026
1 headline in the last 90 days name Paul Elliot Mann; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.